Cart
sales@molnova.com
Oxyquinoline sulfate
CAS No. 134-31-6
Oxyquinoline sulfate( —— )
Catalog No. M21133 CAS No. 134-31-6
Oxyquinoline sulfate is an antiseptic with mild fungistatic bacteriostatic anthelmintic and amebicidal action.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 29 | In Stock |
|
| 1G | 41 | In Stock |
|
Biological Information
-
Product NameOxyquinoline sulfate
-
NoteResearch use only, not for human use.
-
Brief DescriptionOxyquinoline sulfate is an antiseptic with mild fungistatic bacteriostatic anthelmintic and amebicidal action.
-
DescriptionOxyquinoline sulfate is an antiseptic with mild fungistatic bacteriostatic anthelmintic and amebicidal action.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorothers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number134-31-6
-
Formula Weight388.4
-
Molecular Formula2C9H7NO.H2O4S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=S(=O)(O)O.Oc1cccc2cccnc12.Oc1cccc2cccnc12
-
Chemical Name8-Quinolinol hydrogen sulfate (2:1)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Andersen A . Final Amended Report on the Safety Assessment of Oxyquinoline and Oxyquinoline Sulfate as Used in Cosmetics[J]. International Journal of Toxicology 2006 25(1):1-9.
molnova catalog
related products
-
10-O-trans-p-methoxy...
10-O-Trans-p-methoxycinnamoylcatalpol has antioxidant activity with the IC50 value of 0.37 μM/mL in DPPH free radical scavenging assay.
-
Angiotensin I/II 1-6
Angiotensin I/II (1-6) is a peptide (ASP-ARG-VAL-TYR-ILE-HIS) that contains the amino acids 1-6 and is converted from Angiotensin I/II peptide.
-
Naxillin
Naxillin is a non-growth hormone-like molecule that induces lateral root development by positively affecting the IBA to IAA transition at specific sites in the root.
